Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

New Onset Atrial Fibrillation Predicts Heart Failure Progression.

Aleong RG, Sauer WH, Davis G, Bristow MR.

Am J Med. 2014 Jun 12. pii: S0002-9343(14)00479-3. doi: 10.1016/j.amjmed.2014.06.006. [Epub ahead of print]

PMID:
24931393
[PubMed - as supplied by publisher]
2.

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P.

Eur Heart J. 2005 Jul;26(13):1303-8. Epub 2005 Mar 14.

PMID:
15767288
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, Bristow MR.

Eur J Heart Fail. 2013 Mar;15(3):324-33. doi: 10.1093/eurjhf/hfs181. Epub 2012 Dec 7.

PMID:
23223178
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ.

Eur Heart J. 2000 Aug;21(15):1238-45.

PMID:
10924313
[PubMed - indexed for MEDLINE]
Free Article
6.

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators.

J Am Coll Cardiol. 2006 May 16;47(10):1997-2004. Epub 2006 Apr 27.

PMID:
16697316
[PubMed - indexed for MEDLINE]
Free Article
7.

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH.

Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.

PMID:
23470495
[PubMed - indexed for MEDLINE]
Free Article
8.

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.

Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; on behalf of the Beta-Blockers in Heart Failure Collaborative Group.

Lancet. 2014 Sep 2. pii: S0140-6736(14)61373-8. doi: 10.1016/S0140-6736(14)61373-8. [Epub ahead of print]

PMID:
25193873
[PubMed - as supplied by publisher]
9.

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ; HF-ACTION Investigators.

Clin Cardiol. 2013 Oct;36(10):611-20. doi: 10.1002/clc.22181. Epub 2013 Aug 8.

PMID:
23929781
[PubMed - indexed for MEDLINE]
10.

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.

Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B; EMPHASIS-HF Study Investigators.

J Am Coll Cardiol. 2012 May 1;59(18):1598-603. doi: 10.1016/j.jacc.2011.11.063.

PMID:
22538330
[PubMed - indexed for MEDLINE]
Free Article
11.

Outcomes of medicare beneficiaries with heart failure and atrial fibrillation.

Khazanie P, Liang L, Qualls LG, Curtis LH, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Hernandez AF, Piccini JP.

JACC Heart Fail. 2014 Feb;2(1):41-8. doi: 10.1016/j.jchf.2013.11.002. Epub 2014 Jan 25.

PMID:
24622118
[PubMed - in process]
12.

Advanced electrophysiologic mapping systems: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.

PMID:
23074499
[PubMed]
Free PMC Article
13.

Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.

Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ.

Eur J Heart Fail. 2011 Oct;13(10):1111-20. doi: 10.1093/eurjhf/hfr066. Epub 2011 Jun 3.

PMID:
21642293
[PubMed - indexed for MEDLINE]
14.

Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: a prospective hemodynamic study.

Garrigue S, Bordachar P, Reuter S, Jaïs P, Haïssaguerre M, Clementy J.

Card Electrophysiol Rev. 2003 Dec;7(4):315-24. Review.

PMID:
15071245
[PubMed - indexed for MEDLINE]
15.

Rhythm control versus rate control for atrial fibrillation and heart failure.

Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL; Atrial Fibrillation and Congestive Heart Failure Investigators.

N Engl J Med. 2008 Jun 19;358(25):2667-77. doi: 10.1056/NEJMoa0708789.

PMID:
18565859
[PubMed - indexed for MEDLINE]
Free Article
16.

Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.

Schmiegelow MD, Pedersen OD, Køber L, Seibæk M, Abildstrøm SZ, Torp-Pedersen C.

BMC Cardiovasc Disord. 2011 May 14;11:19. doi: 10.1186/1471-2261-11-19.

PMID:
21569543
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.

Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN.

Circulation. 1993 Jun;87(6 Suppl):VI102-10.

PMID:
8500233
[PubMed - indexed for MEDLINE]
18.

Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.

Pedersen OD, Bagger H, Køber L, Torp-Pedersen C; TRACE Study Group.

Int J Cardiol. 2005 Apr 8;100(1):65-71.

PMID:
15820287
[PubMed - indexed for MEDLINE]
19.

Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration.

Shukla HH, Hellkamp AS, James EA, Flaker GC, Lee KL, Sweeney MO, Lamas GA; Mode Selection Trial (MOST) Investigators.

Heart Rhythm. 2005 Mar;2(3):245-51.

PMID:
15851312
[PubMed - indexed for MEDLINE]
20.

Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D.

Circ Heart Fail. 2012 May 1;5(3):322-30. doi: 10.1161/CIRCHEARTFAILURE.111.964122. Epub 2012 Mar 22.

PMID:
22441774
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk